Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
02.02.2017 13:55:00

Services Stocks on Investors' Radar -- Cardinal Health, AmerisourceBergen, GNC Holdings, and McKesson

NEW YORK, February 2, 2017 /PRNewswire/ --

On Wednesday, benchmark US indices were bullish as the NASDAQ Composite closed the trading session up 0.50%; the Dow Jones Industrial Average edged 0.14% higher; and the S&P 500 was slightly up 0.03%. US markets experienced a mixed day by the closing bell yesterday with 3 sectors closing in green, 4 sectors finishing in red, and 2 sectors ending flat for the day. Pre-market today, Stock-Callers.com reviews these four Services stocks: Cardinal Health Inc. (NYSE: CAH), AmerisourceBergen Corporation (NYSE: ABC), GNC Holdings Inc. (NYSE: GNC), and McKesson Corporation (NYSE: MCK). Learn more about these stocks by accessing their free research reports at:

http://stock-callers.com/registration

Cardinal Health  

On Wednesday, shares in Dublin, Ohio headquartered Cardinal Health Inc. recorded a trading volume of 2.56 million shares. The stock ended the day 0.52% higher at $75.35. Shares of the Company, which operates as a healthcare services and products company worldwide, are trading at a PE ratio of 18.28. Cardinal Health's stock has gained 4.70% in the last one month and 10.38% in the previous three months. The Company is trading above its 50-day moving average by 3.51%. Furthermore, Cardinal Health's shares have a Relative Strength Index (RSI) of 56.84.

On January 03rd, 2017, research firm Mizuho downgraded the Company's stock rating from 'Buy' to 'Neutral', with a target price of $79 per share. Free research report on CAH is available at:

http://stock-callers.com/registration/?symbol=CAH


AmerisourceBergen  

On Wednesday, shares in Chesterbrook, Pennsylvania headquartered AmerisourceBergen Corp. ended the session 1.52% higher at $88.61 with a total volume of 3.36 million shares traded. AmerisourceBergen's shares have gained 13.33% in the last one month and 26.60% in the previous three months. Furthermore, the stock has advanced 2.25% in the past one year. Shares of the Company, which sources and distributes pharmaceutical products in the US and internationally, are trading at a PE ratio of 14.00. The stock is trading 9.67% above its 50-day moving average and 9.51% above its 200-day moving average. Moreover, the Company's shares have an RSI of 63.99.

On January 17th, 2017, research firm Leerink Partners upgraded the Company's stock rating from 'Market Perform' to 'Outperform'. The complimentary research report on ABC can be downloaded at:

http://stock-callers.com/registration/?symbol=ABC


GNC Holdings  

Pittsburgh, Pennsylvania headquartered GNC Holdings Inc.'s stock finished Wednesday's session 0.90% lower at $8.79 with a total volume of 2.08 million shares traded. The Company's shares are trading below its 50-day and 200-day moving averages by 27.48% and 55.23%, respectively. Shares of GNC Holdings, which together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products, are trading at a PE ratio of 3.32. The stock has an RSI of 26.14.

On January 19th, 2017, research firm Goldman downgraded the Company's stock rating from 'Neutral' to 'Sell'. Visit us today and access our complete research report on GNC at:

http://stock-callers.com/registration/?symbol=GNC


McKesson  

San Francisco, California headquartered McKesson Corp.'s stock edged 0.63% higher, to close the day at $140.03. The stock recorded a trading volume of 2.79 million shares, which was above its three months average volume of 2.35 million shares. McKesson's shares have gained 10.33% in the last three months. The Company's shares are trading 2.64% and 16.29% below its 50-day and 200-day moving averages, respectively. Shares of the Company, which operates as a pharmaceutical distribution services and information technology company in the US and internationally, are trading at a PE ratio of 15.45. Additionally, the stock has an RSI of 43.16.

On January 18th, 2017, research firm Avondale upgraded the Company's stock rating from 'Market Perform' to 'Market Outperform'. Get free access to your research report on MCK at:

http://stock-callers.com/registration/?symbol=MCK

--

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number:  +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP


CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Chelmsford Park SA

Analysen zu AmerisourceBergen Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

AmerisourceBergen Corp. 236,60 0,21% AmerisourceBergen Corp.
Cardinal Health Inc. 116,20 -0,56% Cardinal Health Inc.
McKesson Corp. 590,80 -0,64% McKesson Corp.